Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24637997

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 May 1
First author
Pujade-Lauraine E

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Dec 10;32(35):4025
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
    note
    Source null
    related pmid
    24637996
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2014 May;11(5):242. doi: 10.1038/nrclinonc.2014.59.
    note
    Source null
    related pmid
    24687034
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.7379.
    note
    Source null
    related pmid
    25185088
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.6231.
    note
    Source null
    related pmid
    25185105
    relationship
    Comment in

Authors and identifiers

  1. name
    Pujade-Lauraine E
    type
    Author
  2. name
    Hilpert F
    type
    Author
  3. name
    Weber B
    type
    Author
  4. name
    Reuss A
    type
    Author
  5. name
    Poveda A
    type
    Author
  6. name
    Kristensen G
    type
    Author
  7. name
    Sorio R
    type
    Author
  8. name
    Vergote I
    type
    Author
  9. name
    Witteveen P
    type
    Author
  10. name
    Bamias A
    type
    Author
  11. name
    Pereira D
    type
    Author
  12. name
    Wimberger P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pujade-Lauraine E
    type
    Author
  2. name
    Hilpert F
    type
    Author
  3. name
    Weber B
    type
    Author
  4. name
    Reuss A
    type
    Author
  5. name
    Poveda A
    type
    Author
  6. name
    Kristensen G
    type
    Author
  7. name
    Sorio R
    type
    Author
  8. name
    Vergote I
    type
    Author
  9. name
    Witteveen P
    type
    Author
  10. name
    Bamias A
    type
    Author
  11. name
    Pereira D
    type
    Author
  12. name
    Wimberger P
    type
    Author
bibliography ids
  1. nci-bib-a600ed827e5506232fbcd4ef
book metadata
content sha256
0c2a9b612e8449aa91eb02b4b40aa8efd9b2e04717efb7587d77c14c7830da31
document type
citation
dois
  1. 10.1200/JCO.2013.51.4489
electronic publication date
display
2014 Mar 17
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24637997
immutable id
pubmed:24637997@0c2a9b612e8449aa91eb02b4b40aa8efd9b2e04717efb7587d77c14c7830da31
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1302-8
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Dec 10;32(35):4025
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
    note
    Source null
    related pmid
    24637996
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2014 May;11(5):242. doi: 10.1038/nrclinonc.2014.59.
    note
    Source null
    related pmid
    24687034
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.7379.
    note
    Source null
    related pmid
    25185088
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.6231.
    note
    Source null
    related pmid
    25185105
    relationship
    Comment in
outcomes validated
false
pmid
24637997
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
2b7628b87660fd0e12219b4d0edd7c7a27c5ae938f530874f7b0b2bc404264a9
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 May 1
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24637997/
title
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.

Preserved source evidence · Not medical advice